| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
176,215 |
157,848 |
$50.23M |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
212,121 |
174,962 |
$9.03M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
97,078 |
88,848 |
$7.55M |
| 90378 |
|
1,372 |
1,133 |
$4.36M |
| 0510 |
|
68,841 |
62,415 |
$3.20M |
| 0450 |
Emergency room services |
38,417 |
36,013 |
$2.80M |
| J1745 |
Injection, infliximab, excludes biosimilar, 10 mg |
1,392 |
1,007 |
$2.76M |
| Q3014 |
Telehealth originating site facility fee |
64,900 |
62,183 |
$2.43M |
| Z5946 |
|
890 |
886 |
$2.42M |
| 99199 |
Unlisted special service, procedure or report |
39,817 |
32,166 |
$2.28M |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
3,531 |
3,358 |
$2.19M |
| Z7500 |
|
176,836 |
166,050 |
$2.09M |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
5,825 |
5,646 |
$1.87M |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
2,990 |
2,441 |
$1.81M |
| 0123 |
|
208 |
203 |
$1.74M |
| 93325 |
|
8,907 |
8,544 |
$1.63M |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
2,330 |
2,179 |
$1.52M |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
2,554 |
2,493 |
$1.48M |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
20,025 |
16,366 |
$1.42M |
| 36455 |
|
3,244 |
2,690 |
$1.41M |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
14,348 |
13,856 |
$1.35M |
| 92557 |
|
17,778 |
17,349 |
$1.30M |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
3,450 |
3,380 |
$1.18M |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
1,058 |
1,039 |
$1.14M |
| 29705 |
|
6,999 |
6,318 |
$1.11M |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
15,074 |
14,755 |
$1.02M |
| X4500 |
|
8,719 |
8,684 |
$822K |
| 97139 |
|
81,261 |
19,064 |
$818K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
102,955 |
64,568 |
$780K |
| 80053 |
Comprehensive metabolic panel |
32,771 |
30,428 |
$778K |
| 99201 |
|
14,126 |
11,846 |
$750K |
| 76770 |
|
5,656 |
5,511 |
$728K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
5,247 |
5,160 |
$697K |
| 99070 |
|
6,300 |
4,815 |
$694K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
46,542 |
30,531 |
$680K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
44,782 |
39,771 |
$644K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
583 |
577 |
$625K |
| 93975 |
|
1,649 |
1,615 |
$615K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
3,379 |
3,007 |
$613K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
5,298 |
4,739 |
$607K |
| 92551 |
|
34,314 |
34,166 |
$597K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
1,126 |
1,118 |
$585K |
| 0360 |
|
480 |
362 |
$575K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
13,701 |
13,367 |
$566K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
4,967 |
4,816 |
$548K |
| J3490 |
Unclassified drugs |
19,692 |
12,769 |
$535K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
4,019 |
2,569 |
$520K |
| 92588 |
|
8,433 |
8,264 |
$491K |
| 95782 |
|
255 |
254 |
$478K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
672 |
669 |
$470K |
| 92567 |
|
17,736 |
17,291 |
$463K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
3,801 |
3,001 |
$455K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
10,151 |
9,953 |
$453K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
3,347 |
3,009 |
$444K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
220 |
220 |
$423K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,125 |
1,108 |
$417K |
| 76825 |
|
2,188 |
2,109 |
$415K |
| 87631 |
|
4,018 |
3,815 |
$412K |
| 73100 |
|
5,081 |
3,958 |
$402K |
| 69210 |
|
1,970 |
1,883 |
$391K |
| 90834 |
Psychotherapy, 45 minutes with patient |
2,700 |
1,197 |
$390K |
| 76827 |
|
2,205 |
2,120 |
$382K |
| 86923 |
|
2,164 |
1,807 |
$382K |
| 31575 |
|
993 |
962 |
$382K |
| 84443 |
Thyroid stimulating hormone (TSH) |
11,220 |
10,978 |
$369K |
| 93304 |
|
3,137 |
3,039 |
$365K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
6,052 |
5,909 |
$361K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
6,046 |
5,906 |
$360K |
| 97802 |
|
2,653 |
2,618 |
$336K |
| 96910 |
|
5,076 |
960 |
$335K |
| 73610 |
|
6,065 |
5,330 |
$330K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
20,543 |
19,932 |
$329K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
869 |
866 |
$328K |
| 71046 |
Radiologic examination, chest; 2 views |
8,133 |
7,856 |
$327K |
| 73090 |
|
5,191 |
4,091 |
$324K |
| 0521 |
|
6,046 |
5,168 |
$324K |
| 29799 |
|
5,055 |
4,317 |
$311K |
| 93976 |
|
1,146 |
1,119 |
$293K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
3,381 |
2,808 |
$293K |
| 29075 |
|
2,377 |
2,294 |
$292K |
| 86003 |
|
27,503 |
2,363 |
$291K |
| 97750 |
|
14,310 |
8,012 |
$291K |
| 73080 |
|
4,759 |
3,895 |
$289K |
| X4540 |
|
8,531 |
8,472 |
$280K |
| 29065 |
|
1,567 |
1,456 |
$278K |
| 93321 |
|
5,143 |
5,007 |
$278K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,393 |
1,913 |
$272K |
| 72082 |
|
2,968 |
2,921 |
$260K |
| 86920 |
|
807 |
663 |
$256K |
| 86480 |
|
2,392 |
2,327 |
$252K |
| 73110 |
|
4,099 |
3,591 |
$250K |
| Z7502 |
|
6,726 |
6,689 |
$250K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
13,975 |
8,785 |
$243K |
| 86922 |
|
690 |
554 |
$240K |
| 73630 |
|
5,130 |
4,196 |
$235K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
3,905 |
3,812 |
$225K |
| T1024 |
Evaluation and treatment by an integrated, specialty team contracted to provide coordinated care to multiple or severely handicapped children, per encounter |
4,574 |
3,741 |
$220K |
| 76870 |
|
2,288 |
2,224 |
$218K |
| 95819 |
|
3,377 |
3,311 |
$217K |
| 86902 |
|
4,041 |
3,455 |
$214K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
1,919 |
1,884 |
$214K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
10,319 |
4,037 |
$212K |
| 0001A |
|
3,893 |
2,035 |
$206K |
| 0700 |
|
3,653 |
3,150 |
$205K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
3,412 |
2,824 |
$203K |
| 73070 |
|
2,725 |
2,305 |
$200K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
12,581 |
8,144 |
$200K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,384 |
1,341 |
$197K |
| 74018 |
|
5,624 |
5,401 |
$192K |
| 0002A |
|
3,610 |
1,888 |
$192K |
| 76536 |
|
1,884 |
1,829 |
$190K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
3,174 |
1,586 |
$190K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
4,929 |
4,852 |
$190K |
| 73140 |
|
4,320 |
3,826 |
$187K |
| 73590 |
|
3,722 |
2,991 |
$186K |
| 97799 |
|
10,211 |
4,510 |
$185K |
| T1999 |
Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" |
5,593 |
3,537 |
$184K |
| 93308 |
|
1,421 |
1,399 |
$184K |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
1,483 |
1,445 |
$183K |
| 82728 |
|
8,097 |
6,976 |
$182K |
| 72170 |
|
4,375 |
4,245 |
$175K |
| 76981 |
|
1,162 |
1,154 |
$174K |
| 97803 |
|
1,599 |
1,567 |
$174K |
| 84439 |
|
9,795 |
9,585 |
$173K |
| 93303 |
Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study |
744 |
710 |
$173K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
5,517 |
5,440 |
$170K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
4,779 |
3,983 |
$167K |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
20,190 |
16,014 |
$164K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
2,686 |
2,543 |
$154K |
| 92582 |
|
3,956 |
3,908 |
$152K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
3,644 |
3,403 |
$151K |
| 73130 |
|
2,784 |
2,444 |
$150K |
| 92579 |
|
5,588 |
5,467 |
$146K |
| 87390 |
|
4,768 |
4,701 |
$144K |
| 94664 |
|
5,662 |
5,276 |
$144K |
| 99417 |
Prolong home eval add 15m |
1,961 |
1,722 |
$143K |
| 87088 |
|
10,026 |
9,573 |
$136K |
| 87486 |
|
2,553 |
2,492 |
$135K |
| 87581 |
|
2,554 |
2,493 |
$135K |
| 86141 |
|
6,487 |
6,024 |
$134K |
| 0272 |
|
1,206 |
1,089 |
$129K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
272 |
270 |
$126K |
| 86364 |
|
2,876 |
1,929 |
$125K |
| 99215 |
Prolong outpt/office vis |
3,219 |
2,139 |
$123K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
5,898 |
3,662 |
$121K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
48,649 |
31,239 |
$117K |
| X4303 |
|
1,773 |
1,242 |
$115K |
| 95816 |
|
1,280 |
1,253 |
$113K |
| 81001 |
|
16,113 |
15,376 |
$111K |
| G9920 |
Screening performed and negative |
6,312 |
6,270 |
$110K |
| 87077 |
|
4,826 |
4,289 |
$110K |
| 73562 |
|
2,270 |
2,027 |
$107K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,363 |
2,213 |
$106K |
| 29405 |
|
406 |
355 |
$103K |
| 73564 |
|
2,290 |
2,070 |
$103K |
| 86235 |
|
384 |
364 |
$102K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
2,546 |
2,493 |
$102K |
| 83718 |
|
6,826 |
6,743 |
$101K |
| 83516 |
|
6,046 |
2,841 |
$101K |
| 84703 |
|
9,878 |
9,261 |
$101K |
| 0071A |
|
1,861 |
993 |
$99K |
| 86702 |
|
4,784 |
4,724 |
$98K |
| 76885 |
|
825 |
776 |
$98K |
| Z4300 |
|
950 |
944 |
$98K |
| Z5822 |
|
3,541 |
2,750 |
$97K |
| G9002 |
Coordinated care fee, maintenance rate |
483 |
435 |
$95K |
| 0072A |
|
1,803 |
989 |
$95K |
| 81003 |
|
11,243 |
10,747 |
$92K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
5,300 |
5,155 |
$92K |
| 97161 |
|
2,517 |
1,394 |
$92K |
| 92700 |
|
1,680 |
1,443 |
$90K |
| 93320 |
|
849 |
811 |
$89K |
| 94799 |
|
649 |
642 |
$88K |
| T1001 |
Nursing assessment / evaluation |
1,610 |
1,512 |
$86K |
| 84466 |
|
3,422 |
3,310 |
$85K |
| 72081 |
|
1,782 |
1,762 |
$84K |
| 98967 |
|
2,425 |
1,848 |
$83K |
| 83020 |
|
3,918 |
2,274 |
$82K |
| 93226 |
|
670 |
650 |
$81K |
| 84403 |
|
1,927 |
1,899 |
$81K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
994 |
974 |
$81K |
| 76820 |
|
1,755 |
1,611 |
$80K |
| 90837 |
Psychotherapy, 53 minutes with patient |
664 |
332 |
$80K |
| 76813 |
|
570 |
564 |
$76K |
| 83690 |
|
4,695 |
4,581 |
$76K |
| 0780 |
|
1,527 |
1,521 |
$75K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
864 |
620 |
$75K |
| 0761 |
|
1,668 |
1,578 |
$75K |
| 85018 |
|
23,590 |
23,237 |
$75K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
673 |
648 |
$74K |
| 0760 |
|
1,864 |
1,643 |
$74K |
| Z7610 |
|
5,817 |
4,137 |
$74K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
4,881 |
4,684 |
$73K |
| 82784 |
|
5,678 |
4,445 |
$72K |
| 74019 |
|
1,551 |
1,504 |
$72K |
| 94010 |
|
2,487 |
2,416 |
$71K |
| 86701 |
|
4,786 |
4,725 |
$69K |
| 90686 |
|
13,114 |
11,475 |
$68K |
| 83721 |
|
4,129 |
4,072 |
$67K |
| 82803 |
|
1,136 |
1,073 |
$67K |
| 87081 |
|
4,994 |
4,857 |
$67K |
| Z5406 |
|
3,892 |
3,031 |
$67K |
| 82330 |
|
1,843 |
1,696 |
$66K |
| 86481 |
|
502 |
490 |
$66K |
| Z4301 |
|
2,354 |
2,314 |
$65K |
| 99368 |
|
3,060 |
2,325 |
$65K |
| Z5932 |
|
1,349 |
1,347 |
$65K |
| Z5958 |
|
405 |
393 |
$65K |
| X4542 |
|
1,061 |
1,053 |
$65K |
| P9022 |
Red blood cells, washed, each unit |
84 |
52 |
$63K |
| 73221 |
|
89 |
86 |
$63K |
| 73552 |
|
1,278 |
1,082 |
$63K |
| 29125 |
|
682 |
663 |
$62K |
| 77073 |
|
1,548 |
1,504 |
$61K |
| 54161 |
|
49 |
49 |
$61K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
3,471 |
3,442 |
$61K |
| 84305 |
|
1,909 |
1,879 |
$60K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
1,474 |
1,284 |
$59K |
| 93225 |
|
729 |
701 |
$59K |
| J3380 |
Injection, vedolizumab, intravenous, 1 mg |
50 |
13 |
$58K |
| 73000 |
|
1,514 |
1,352 |
$58K |
| 72141 |
|
89 |
87 |
$57K |
| 77072 |
|
2,238 |
2,207 |
$56K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
212 |
211 |
$54K |
| 82465 |
|
7,004 |
6,913 |
$54K |
| 71045 |
Radiologic examination, chest; single view |
1,805 |
1,761 |
$53K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
37 |
37 |
$51K |
| Z4308 |
|
1,878 |
1,873 |
$50K |
| 86850 |
|
5,463 |
4,633 |
$50K |
| 91320 |
|
358 |
358 |
$49K |
| 83993 |
|
1,520 |
1,417 |
$49K |
| 96127 |
|
9,125 |
9,010 |
$49K |
| 92060 |
|
2,882 |
2,818 |
$49K |
| 82670 |
|
1,108 |
1,088 |
$49K |
| 90682 |
|
1,620 |
1,595 |
$49K |
| 73030 |
|
996 |
929 |
$48K |
| S0265 |
Genetic counseling, under physician supervision, each 15 minutes |
764 |
738 |
$48K |
| 84478 |
|
4,396 |
4,275 |
$47K |
| 82785 |
|
1,378 |
1,347 |
$47K |
| 83540 |
|
3,515 |
3,395 |
$46K |
| 82948 |
|
7,610 |
7,341 |
$46K |
| 87040 |
|
1,761 |
1,669 |
$46K |
| 92595 |
|
503 |
452 |
$46K |
| X4110 |
|
1,471 |
1,057 |
$45K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
2,063 |
1,681 |
$44K |
| 11900 |
|
312 |
308 |
$44K |
| 92522 |
|
364 |
352 |
$44K |
| 99000 |
|
5,423 |
5,171 |
$44K |
| 83550 |
|
3,133 |
3,029 |
$44K |
| 85045 |
|
6,011 |
5,482 |
$43K |
| 80051 |
|
1,244 |
1,177 |
$43K |
| 73560 |
|
977 |
791 |
$42K |
| 84100 |
|
5,169 |
4,358 |
$42K |
| 93786 |
|
641 |
639 |
$42K |
| 84460 |
|
4,349 |
4,304 |
$41K |
| 70486 |
|
103 |
102 |
$40K |
| 17110 |
|
1,283 |
1,250 |
$39K |
| 94644 |
|
1,076 |
1,009 |
$39K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,162 |
2,094 |
$39K |
| 91319 |
|
397 |
397 |
$38K |
| Z4303 |
|
881 |
870 |
$38K |
| Z4307 |
|
1,303 |
1,291 |
$38K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
4,495 |
4,352 |
$37K |
| 90381 |
|
40 |
39 |
$37K |
| 87799 |
|
652 |
455 |
$37K |
| V5264 |
Ear mold/insert, not disposable, any type |
667 |
662 |
$37K |
| 72100 |
|
628 |
623 |
$37K |
| 87070 |
|
2,269 |
2,189 |
$36K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,914 |
2,085 |
$36K |
| 86803 |
|
1,256 |
1,248 |
$36K |
| 99188 |
|
973 |
952 |
$35K |
| 82397 |
|
1,758 |
1,733 |
$34K |
| 73060 |
|
740 |
647 |
$34K |
| 84450 |
|
3,678 |
3,643 |
$33K |
| 84402 |
|
802 |
794 |
$33K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
6,600 |
5,554 |
$33K |
| 97010 |
|
766 |
277 |
$33K |
| 0710 |
|
438 |
427 |
$33K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
6,719 |
3,884 |
$33K |
| 31231 |
|
163 |
160 |
$33K |
| 83605 |
|
1,220 |
1,138 |
$33K |
| 86258 |
|
1,179 |
606 |
$33K |
| 83735 |
|
2,302 |
2,043 |
$33K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
1,368 |
1,315 |
$33K |
| 86140 |
|
3,465 |
3,337 |
$32K |
| Z4304 |
|
416 |
415 |
$32K |
| Z4311 |
|
2,561 |
2,510 |
$32K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
6,573 |
5,663 |
$32K |
| 86901 |
|
5,728 |
4,868 |
$31K |
| 87184 |
|
3,080 |
2,949 |
$31K |
| 83001 |
|
1,216 |
1,187 |
$31K |
| 85027 |
|
2,334 |
2,266 |
$30K |
| 83002 |
|
1,033 |
1,021 |
$30K |
| 98960 |
|
417 |
412 |
$30K |
| S9470 |
Nutritional counseling, dietitian visit |
598 |
514 |
$30K |
| 86900 |
|
5,727 |
4,867 |
$30K |
| 83655 |
|
5,862 |
5,781 |
$29K |
| 92504 |
|
913 |
850 |
$29K |
| 82565 |
|
3,252 |
3,211 |
$29K |
| 86008 |
|
900 |
139 |
$28K |
| 82977 |
|
2,002 |
1,808 |
$28K |
| 85660 |
|
1,927 |
1,241 |
$27K |
| 0636 |
|
181 |
176 |
$27K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
155 |
140 |
$27K |
| 90461 |
|
18,415 |
11,984 |
$27K |
| 94060 |
|
484 |
475 |
$27K |
| 73660 |
|
703 |
625 |
$27K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
29 |
27 |
$27K |
| 30901 |
|
117 |
115 |
$26K |
| 72146 |
|
37 |
37 |
$26K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,240 |
1,159 |
$26K |
| 85246 |
|
522 |
507 |
$26K |
| 85651 |
|
4,177 |
4,013 |
$26K |
| 92081 |
|
442 |
434 |
$25K |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
4,205 |
3,697 |
$25K |
| 86592 |
|
3,127 |
3,068 |
$25K |
| 90691 |
|
216 |
214 |
$25K |
| 25605 |
|
81 |
79 |
$25K |
| X4532 |
|
728 |
728 |
$24K |
| 84145 |
|
546 |
520 |
$24K |
| 0054A |
|
444 |
247 |
$24K |
| 87340 |
|
1,148 |
1,124 |
$24K |
| 85652 |
|
4,662 |
4,493 |
$24K |
| 85245 |
|
484 |
471 |
$23K |
| 76882 |
|
1,068 |
998 |
$23K |
| 97804 |
|
481 |
479 |
$23K |
| X4530 |
|
470 |
469 |
$22K |
| 36600 |
|
739 |
711 |
$22K |
| 99366 |
|
1,029 |
916 |
$22K |
| 82570 |
|
2,297 |
2,195 |
$22K |
| 86256 |
|
1,118 |
1,054 |
$21K |
| 85610 |
|
2,494 |
2,351 |
$21K |
| 0270 |
|
27 |
26 |
$21K |
| 86706 |
|
937 |
915 |
$21K |
| Z4312 |
|
1,704 |
1,701 |
$21K |
| 85730 |
|
1,565 |
1,463 |
$20K |
| 86038 |
|
875 |
868 |
$20K |
| 82947 |
|
2,513 |
2,413 |
$20K |
| 82610 |
|
998 |
948 |
$19K |
| 12011 |
|
482 |
468 |
$19K |
| 83615 |
|
1,532 |
1,406 |
$19K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
193 |
190 |
$19K |
| 85240 |
|
497 |
477 |
$19K |
| 76826 |
|
95 |
93 |
$18K |
| 74240 |
|
141 |
137 |
$18K |
| X3908 |
|
583 |
304 |
$18K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
105 |
105 |
$18K |
| 84520 |
|
2,527 |
2,504 |
$17K |
| X4304 |
|
535 |
322 |
$17K |
| 85384 |
|
791 |
735 |
$17K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
995 |
460 |
$17K |
| 72190 |
|
514 |
500 |
$17K |
| 92511 |
|
116 |
116 |
$16K |
| 82627 |
|
348 |
346 |
$16K |
| 36512 |
|
12 |
12 |
$16K |
| J0134 |
Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg |
452 |
418 |
$16K |
| 83498 |
|
758 |
754 |
$15K |
| 0052A |
|
277 |
150 |
$15K |
| X4522 |
|
46 |
43 |
$15K |
| V5267 |
Hearing aid or assistive listening device/supplies/accessories, not otherwise specified |
192 |
190 |
$15K |
| 87205 |
|
1,754 |
1,708 |
$15K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
1,972 |
1,023 |
$14K |
| J7050 |
Infusion, normal saline solution, 250 cc |
1,325 |
962 |
$14K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
928 |
747 |
$14K |
| 87497 |
|
224 |
146 |
$14K |
| 94770 |
|
531 |
516 |
$14K |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
1,256 |
1,190 |
$13K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
204 |
107 |
$13K |
| 80061 |
Lipid panel |
448 |
444 |
$13K |
| 29105 |
|
119 |
118 |
$13K |
| J2704 |
Injection, propofol, 10 mg |
3,134 |
2,651 |
$12K |
| X4112 |
|
1,160 |
866 |
$12K |
| 92585 |
|
80 |
77 |
$12K |
| 76506 |
|
145 |
142 |
$11K |
| 92650 |
|
38 |
32 |
$11K |
| 99156 |
|
80 |
71 |
$11K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
696 |
664 |
$11K |
| 0004A |
|
201 |
107 |
$11K |
| 83525 |
|
501 |
456 |
$11K |
| 83030 |
|
777 |
738 |
$11K |
| 70360 |
|
309 |
302 |
$10K |
| 76828 |
|
95 |
93 |
$10K |
| 72020 |
|
151 |
150 |
$10K |
| 84550 |
|
963 |
934 |
$10K |
| 92594 |
|
202 |
193 |
$9K |
| 12001 |
|
176 |
173 |
$9K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
37 |
37 |
$9K |
| 86376 |
|
540 |
530 |
$9K |
| 97165 |
|
195 |
95 |
$9K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,128 |
1,019 |
$9K |
| 0051A |
|
169 |
86 |
$9K |
| 90832 |
Psychotherapy, 30 minutes with patient |
181 |
125 |
$9K |
| 90656 |
|
1,482 |
1,464 |
$9K |
| 84480 |
|
281 |
270 |
$8K |
| Z4310 |
|
503 |
492 |
$8K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,597 |
1,497 |
$8K |
| 84156 |
|
1,169 |
1,131 |
$8K |
| G2012 |
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion |
633 |
602 |
$8K |
| Q0144 |
Azithromycin dihydrate, oral, capsules/powder, 1 gram |
248 |
230 |
$8K |
| 69200 |
|
27 |
25 |
$8K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,034 |
1,947 |
$7K |
| 80076 |
|
467 |
454 |
$7K |
| 86682 |
|
330 |
328 |
$7K |
| 93788 |
|
640 |
638 |
$7K |
| 91318 |
|
100 |
99 |
$7K |
| 0124A |
|
116 |
116 |
$7K |
| 99080 |
|
79 |
63 |
$7K |
| 51798 |
|
28 |
27 |
$7K |
| 96409 |
|
242 |
157 |
$7K |
| J9370 |
Vincristine sulfate, 1 mg |
544 |
310 |
$7K |
| 99205 |
Prolong outpt/office vis |
62 |
61 |
$7K |
| 87427 |
|
350 |
172 |
$7K |
| 82550 |
|
423 |
412 |
$6K |
| Z4309 |
|
136 |
136 |
$6K |
| 87177 |
|
346 |
183 |
$6K |
| 82043 |
|
600 |
575 |
$6K |
| X3910 |
|
509 |
264 |
$6K |
| 0154A |
|
112 |
112 |
$6K |
| 84146 |
|
180 |
179 |
$6K |
| 11750 |
|
48 |
44 |
$6K |
| 87045 |
|
333 |
316 |
$6K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
654 |
593 |
$6K |
| 90688 |
|
238 |
216 |
$6K |
| 0074A |
|
88 |
88 |
$6K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
14 |
13 |
$6K |
| 29345 |
|
12 |
12 |
$5K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
257 |
255 |
$5K |
| 87634 |
|
62 |
60 |
$5K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
1,005 |
940 |
$5K |
| 87046 |
|
975 |
316 |
$5K |
| J7042 |
5% dextrose/normal saline (500 ml = 1 unit) |
832 |
774 |
$5K |
| 85007 |
|
711 |
662 |
$5K |
| 83970 |
|
55 |
53 |
$5K |
| V5140 |
Binaural, behind the ear |
123 |
122 |
$5K |
| 95812 |
|
74 |
73 |
$5K |
| 70544 |
|
12 |
12 |
$5K |
| 96415 |
|
94 |
91 |
$5K |
| 99218 |
|
78 |
78 |
$5K |
| 87147 |
|
590 |
505 |
$5K |
| 86160 |
|
202 |
107 |
$5K |
| G9919 |
Screening performed and positive and provision of recommendations |
167 |
161 |
$4K |
| 82103 |
|
418 |
417 |
$4K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
12 |
12 |
$4K |
| H2015 |
Comprehensive community support services, per 15 minutes |
90 |
84 |
$4K |
| 92610 |
|
90 |
85 |
$4K |
| 73600 |
|
40 |
37 |
$4K |
| 92604 |
|
54 |
51 |
$4K |
| 87015 |
|
326 |
309 |
$4K |
| 54640 |
|
15 |
12 |
$4K |
| 95700 |
|
12 |
12 |
$4K |
| Z5936 |
|
45 |
45 |
$4K |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
55 |
45 |
$4K |
| 73620 |
|
27 |
25 |
$4K |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
3,445 |
3,128 |
$4K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
979 |
915 |
$4K |
| 82247 |
|
463 |
362 |
$4K |
| 74230 |
|
53 |
53 |
$4K |
| 76642 |
|
30 |
24 |
$3K |
| J8540 |
Dexamethasone, oral, 0.25 mg |
862 |
818 |
$3K |
| X4100 |
|
67 |
67 |
$3K |
| 85576 |
|
77 |
70 |
$3K |
| 94645 |
|
89 |
86 |
$3K |
| J1720 |
Injection, hydrocortisone sodium succinate, up to 100 mg |
192 |
94 |
$3K |
| 82104 |
|
318 |
317 |
$3K |
| 86708 |
|
144 |
144 |
$3K |
| J0136 |
Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg |
103 |
98 |
$3K |
| Z7504 |
|
59 |
42 |
$3K |
| 82657 |
|
89 |
60 |
$3K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
131 |
94 |
$3K |
| 82390 |
|
430 |
424 |
$3K |
| 29515 |
|
47 |
47 |
$3K |
| X4301 |
|
29 |
29 |
$3K |
| 90791 |
Psychiatric diagnostic evaluation |
48 |
46 |
$3K |
| 92603 |
|
25 |
24 |
$3K |
| 82248 |
|
278 |
241 |
$3K |
| 83986 |
|
261 |
235 |
$3K |
| 86704 |
|
84 |
83 |
$3K |
| X4300 |
|
26 |
26 |
$2K |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
114 |
102 |
$2K |
| 99157 |
|
15 |
13 |
$2K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
419 |
372 |
$2K |
| 96112 |
|
15 |
15 |
$2K |
| 94760 |
|
166 |
162 |
$2K |
| 71020 |
|
67 |
53 |
$2K |
| 84202 |
|
72 |
66 |
$2K |
| 87101 |
|
175 |
172 |
$2K |
| 80299 |
|
112 |
110 |
$2K |
| X3920 |
|
42 |
41 |
$2K |
| 86225 |
|
76 |
76 |
$2K |
| 87481 |
|
50 |
25 |
$2K |
| 99221 |
|
27 |
27 |
$2K |
| 0112A |
|
30 |
30 |
$2K |
| Z5928 |
|
43 |
43 |
$2K |
| 0082A |
|
29 |
29 |
$2K |
| 86665 |
|
211 |
111 |
$2K |
| 80069 |
|
98 |
95 |
$2K |
| 86880 |
|
189 |
157 |
$2K |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
328 |
308 |
$2K |
| 93971 |
|
15 |
14 |
$2K |
| 85670 |
|
130 |
129 |
$2K |
| 86800 |
|
66 |
59 |
$2K |
| 72070 |
|
14 |
14 |
$2K |
| 90651 |
|
509 |
422 |
$2K |
| 0081A |
|
26 |
26 |
$2K |
| G9019 |
Oseltamivir phosphate, oral, per 75 mg (for use in a medicare-approved demonstration project) |
109 |
89 |
$2K |
| Z7506 |
|
12 |
12 |
$2K |
| 94726 |
|
24 |
24 |
$1K |
| 82652 |
|
78 |
76 |
$1K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
143 |
133 |
$1K |
| 87807 |
|
79 |
71 |
$1K |
| 84445 |
|
26 |
25 |
$1K |
| 99173 |
|
17,845 |
17,302 |
$1K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
18 |
18 |
$1K |
| J2274 |
Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg |
137 |
126 |
$1K |
| 72040 |
|
24 |
24 |
$1K |
| 92526 |
|
29 |
26 |
$1K |
| 11730 |
|
13 |
12 |
$1K |
| 92523 |
|
16 |
16 |
$1K |
| V5020 |
Conformity evaluation |
13 |
13 |
$1K |
| 77080 |
|
25 |
25 |
$1K |
| 74000 |
|
52 |
38 |
$1K |
| 29700 |
|
19 |
19 |
$1K |
| 86308 |
|
98 |
93 |
$1K |
| 81513 |
|
25 |
25 |
$1K |
| 86663 |
|
111 |
111 |
$1K |
| 86664 |
|
111 |
111 |
$1K |
| J7999 |
Compounded drug, not otherwise classified |
75 |
67 |
$950.17 |
| 0250 |
|
284 |
238 |
$942.58 |
| 94729 |
|
12 |
12 |
$916.88 |
| V5266 |
Battery for use in hearing device |
13 |
13 |
$914.11 |
| 87186 |
|
74 |
69 |
$901.92 |
| 92250 |
|
44 |
44 |
$876.29 |
| 84630 |
|
152 |
149 |
$874.24 |
| G2063 |
Qualified nonphysician healthcare professional online assessment and management service, for an established patient, for up to seven days, cumulative time during the 7 days; 21 or more minutes |
21 |
12 |
$855.54 |
| 82985 |
|
95 |
89 |
$855.40 |
| 92587 |
|
15 |
15 |
$806.77 |
| 0111A |
|
12 |
12 |
$804.00 |
| 36415 |
Collection of venous blood by venipuncture |
2,799 |
2,670 |
$796.06 |
| 92570 |
|
16 |
14 |
$791.55 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
175 |
157 |
$778.89 |
| 87209 |
|
48 |
43 |
$723.36 |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
39 |
28 |
$700.00 |
| 70250 |
|
12 |
12 |
$695.14 |
| 85008 |
|
410 |
378 |
$669.75 |
| Z7512 |
|
25 |
25 |
$653.25 |
| X3922 |
|
25 |
24 |
$651.00 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
43 |
42 |
$629.08 |
| 90685 |
|
17 |
17 |
$626.54 |
| A9150 |
Non-prescription drugs |
1,633 |
1,558 |
$603.74 |
| 86580 |
|
57 |
48 |
$552.91 |
| 86705 |
|
26 |
26 |
$538.69 |
| 92611 |
|
17 |
17 |
$525.10 |
| 87210 |
|
82 |
78 |
$493.55 |
| 84484 |
|
26 |
26 |
$481.83 |
| 80143 |
|
13 |
13 |
$478.59 |
| 82085 |
|
71 |
65 |
$451.30 |
| 84590 |
|
26 |
25 |
$432.53 |
| 86015 |
|
93 |
91 |
$403.74 |
| 87338 |
|
12 |
12 |
$386.14 |
| 80179 |
|
12 |
12 |
$374.97 |
| X4102 |
|
13 |
13 |
$357.00 |
| 90670 |
|
548 |
493 |
$333.03 |
| 99408 |
|
4,472 |
4,455 |
$314.75 |
| 84446 |
|
26 |
26 |
$311.60 |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
15 |
12 |
$302.01 |
| 90647 |
|
248 |
219 |
$301.00 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
27 |
26 |
$291.87 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
142 |
133 |
$283.32 |
| 99001 |
|
3,177 |
3,121 |
$256.55 |
| 83921 |
|
14 |
14 |
$256.12 |
| 82157 |
|
12 |
12 |
$246.96 |
| 88304 |
|
12 |
12 |
$245.85 |
| 86709 |
|
14 |
14 |
$223.30 |
| 84270 |
|
14 |
14 |
$220.22 |
| 76000 |
|
13 |
12 |
$200.09 |
| 82150 |
|
12 |
12 |
$182.81 |
| 90723 |
|
139 |
124 |
$153.01 |
| Z4302 |
|
12 |
12 |
$144.60 |
| 90480 |
|
440 |
439 |
$120.00 |
| 90633 |
|
401 |
346 |
$101.01 |
| 99245 |
|
80 |
78 |
$89.38 |
| 0320 |
|
81 |
79 |
$84.94 |
| 90734 |
|
350 |
305 |
$72.02 |
| 99383 |
|
35 |
26 |
$60.31 |
| 85014 |
|
12 |
12 |
$57.31 |
| 90680 |
|
45 |
38 |
$45.00 |
| 90681 |
|
12 |
12 |
$36.00 |
| 0370 |
|
60 |
58 |
$28.50 |
| A6250 |
Skin sealants, protectants, moisturizers, ointments, any type, any size |
65 |
53 |
$14.32 |
| 96160 |
|
578 |
559 |
$7.94 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
53 |
50 |
$3.66 |
| A4217 |
Sterile water/saline, 500 ml |
12 |
12 |
$0.13 |
| 90716 |
|
13 |
12 |
$0.01 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
884 |
849 |
$0.00 |
| 90715 |
|
139 |
121 |
$0.00 |
| 90710 |
|
100 |
88 |
$0.00 |
| 0300 |
|
28 |
28 |
$0.00 |
| 97810 |
|
41 |
29 |
$0.00 |
| 90648 |
|
14 |
12 |
$0.00 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
160 |
151 |
$0.00 |
| 0258 |
|
197 |
193 |
$0.00 |
| 3008F |
|
16 |
16 |
$0.00 |
| 91315 |
|
26 |
26 |
$0.00 |
| 0305 |
|
108 |
107 |
$0.00 |
| 0306 |
|
85 |
81 |
$0.00 |
| 90696 |
|
72 |
63 |
$0.00 |
| 0301 |
|
99 |
97 |
$0.00 |
| 0307 |
|
26 |
26 |
$0.00 |
| 97166 |
|
12 |
12 |
$0.00 |
| 0410 |
|
27 |
26 |
$0.00 |